Atlas Trials

Tumor-microenvironment Spatial Interaction to Identify Markers of Resistance to Therapy in HER2+ Breast Cancer Patients

Clinical trial NCT06518382 · RECRUITING

Trial details

NCT number
NCT06518382
Sponsor
Giampaolo Bianchini
Status
RECRUITING
Study type
OBSERVATIONAL
HER2-positive Breast Cancer
Start date
2024-12-10
Primary completion
2026-12-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.